Replies to post #748956 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I can definitively say that Telix, not NWBO, is the outlier here.

Nope.

Most all dev stage bios keep investors well informed of regulatory plans. For BPs it gets less critical as they have more. And they often do not mention the small market countries.

There us a reason dev stage bios keep investors informed. But NWBO prefers the darkness to hide from the shadows.

[LessIsMore]

Telix, not NWBO, is the outlier here

That's the funniest thing I've heard in months, please continue LOL.

[ilovetech]

Telix is down 0.97% today.

[FeMike]

I can definitively say that Telix, not NWBO, is the outlier here.

There's a lot of stuff you have said "definitively" recently that has turned out to be oddly not definite.

You wanna know where NWBO is an outlier? How about >365 days since they've issued a PR talking about their only product that is anywhere close to sales? Can you show me some companies that have no revenue and have gone a full, entire, literal year without issuing a PR about their progress in getting to sales?

Can you show me some companies that took >3 years from data lock of their flagship drug before submitting an application to a regulator to market that product?

Can you show me any biotech in the world with zero revenue and a CEO that takes home a base salary of $1,000,000 a year?

NWBO is an outlier, that's for damn sure.

[iclight]

It's easier with a product that works too.